is an IP litigation associate with a background in biomedical sciences. Brett acts in patent litigation and life science regulatory matters involving pharmaceuticals, biologics, vaccines, genetic technologies and medical devices. He also acts in hi-tech matters, and has a particular interest in IP and antitrust issues arising in the context of SEP licensing and FRAND royalty disputes. He has experience of acting in multi-jurisdictional patent disputes involving cross-border co-ordination, and in complex damages enquiries.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.